For patients transitioning from rituximab to ravulizumab, meningococcal vaccination can be safely done within 6 months after stopping rituximab.

The story has been updated to correct the FDA approval date to Friday, February 14 On Friday, February 14, the FDA approved ...

NHS England said the ‘potential’ introduction of a varicella vaccine could be launched in January 2026, subject to ‘final ...

Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...

GSK has garnered FDA approval for its pentavalent meningococcal vaccine Penmenvy, tipped as one of its major launches for ...

The US Food and Drug Administration (FDA) has approved GSK’s pentavalent meningococcal vaccine, Penmenvy, for children and ...

Whatcom County Health and Community Services will host seven vaccine clinics this year, with no-cost vaccines available for children and adults without medical insurance.

GSK's Penmenvy wins FDA approval to protect against five meningococcal serogroups. The CDC panel will vote on usage ...